Home › Funds › Eversept Partners, LP › CHE
Eversept Partners, LP position in CHE
CHEMED CORP NEW · Health Care
Eversept Partners, LP reported holding 52,523 shares of CHE (CHEMED CORP NEW) in its Q2 2026 13F filing — a position valued at US$24.5M, representing 1.28% of its reported portfolio and ranking #19 among its reported holdings. Eversept Partners, LP has disclosed CHE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's CHE position evolved
Eversept Partners, LP first disclosed a stake in CHE in Q1 2026 at 31,057 shares (US$11.7M). The position peaked in Q2 2026 at 52,523 shares, worth US$24.5M. Across 2 filings, Eversept Partners, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 52,523 shares valued at US$24.5M — an increase of 21,466 shares quarter over quarter.. Notable position changes include a 69% increase in Q2 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 31.06K | $11.73M | New |
| Q2 2026 | 52.52K | $24.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CHE and 13F data
CHE (CHEMED CORP NEW) is a Health Care company. 25 other funds we track also report a position in CHE — the largest reported positions include Epoch Investment Partners, Inc. (US$124.5M), River Road Asset Management, LLC (US$110.8M), Boston Trust Walden Corp (US$93.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CHE
- Epoch Investment Partners, Inc. 267.29K sh · $124.49M · Q2 2026
- River Road Asset Management, LLC 237.93K sh · $110.81M · Q2 2026
- Boston Trust Walden Corp 201.28K sh · $93.74M · Q2 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held CHE?
Eversept Partners, LP has disclosed CHE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Eversept Partners, LP's current position in CHE?
As of Q2 2026, Eversept Partners, LP holds 52.52K shares of CHE (CHEMED CORP NEW), valued at $24.46M, representing 1.28% of its reported portfolio and ranking #19.
Has Eversept Partners, LP been buying or selling CHE?
In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in CHE. The position peaked in Q2 2026 at 52.52K shares.
Which other funds hold CHE?
Other major institutional holders of CHE include Epoch Investment Partners, Inc., River Road Asset Management, LLC, Boston Trust Walden Corp, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.